Davies, Andrew
Trask, Peter
Demeter, Judit
Florschütz, Axel
Hänel, Mathias
Kinoshita, Tomohiro
Pettengell, Ruth
Quach, Hang
Robinson, Stephen
Sadullah, Shalal
Sancho, Juan-Manuel
Udvardy, Miklos
Witzens-Harig, Mathias
Knapp, Andrea
Liu, Wenxin
Funding for this research was provided by:
Roche (.)
Article History
Received: 4 October 2019
Accepted: 2 April 2020
First Online: 20 April 2020
Compliance with ethical standards
:
: AD, research funding (Celgene), research support (F. Hoffmann-La Roche Ltd., Gilead/Kite, Takeda, GSK, Karyopharm, Pfizer, Acerta Pharma), advisory board participation (Celgene, F. Hoffmann-La Roche Ltd., Gilead/Kite,Takeda, Karyopharm, Acerta Pharma), honoraria (Celgene, F. Hoffmann-La Roche Ltd., Gilead/Kite, Takeda, Janssen, Pfizer, Acerta Pharma), and travel to scientific conferences (Takeda). PT, employment (Genentech Inc). HQ, research funding (Celgene, Amgen) and advisory board participation (Celgene, Amgen, GSK, Karyopharm, Takeda). SR, advisory board participation, speaker fees, and honoraria (F. Hoffmann-La Roche Ltd., Takeda, Novartis, Gilead, Sandoz). TK, research funding (Chugai, Takeda, Solaisia, Ono, Gilead, MSD, Zenyaku) and personal fees (Chugai, Ono, Gilead, MSD, Zenyaku, Bristol, Kyowa Kirin, Eisai, Janssen). RP, personal fees (CTI Life Sciences Ltd., Roche, Servier, Takeda) and advisory board participation (CTI Life Sciences Ltd., G1 Therapeutics Inc., Immune Design, Pfizer, F. Hoffmann-La Roche Ltd., Servier, Takeda, TEVA). JMS, honoraria (F. Hoffmann-La Roche Ltd., Gilead, Janssen, Celgene, Novartis, Mundipharma, Kern-Pharma, Sanofi) and advisory board participation (F. Hoffmann-La Roche Ltd., Gilead, Janssen, Celgene, Celltrion, Sandoz, Bristol-Myers Sqibb). MH, honoraria (Novartis, Amgen, F. Hoffmann-La Roche Ltd) and advisory board participation (Celgene, Takeda). SS, advisory board participation (Takeda, NAPP Pharmaceuticals) and personal fees (Janssen, Novartis). AK and WL, employment (F. Hoffmann-La Roche Ltd). The remaining authors declare no conflicts of interest.
: GALLIUM was conducted in accordance with the Declaration of Helsinki and the International Council for Harmonisation guidelines for Good Clinical Practice. The protocol was approved by the ethics committees of participating centers and is registered at ExternalRef removed.
: Informed consent was obtained from all individual participants included in the study.